Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

OMALIZUMAB

FDA · BLA · 2026-08-06

AgencyFDA
Submission typeBLA
Action date2026-08-06
BrandXOLAIR
SponsorGENENTECH
RouteNot stated

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:34.697Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:OMALIZUMAB:2026-08-06

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

OMALIZUMAB — approval | AEaH